Search

everythinglearnresearchcommunity

for

Search:↓

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

MK-5108 is safe and shows potential against tumors, especially alone.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Provenge extends prostate cancer survival by about 4 months.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

ATP helps prevent skin damage from vandetanib by reducing stress.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Adding a second method to PROTACs could improve cancer treatment.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Antioxidants can block the cancer-fighting effects of doxorubicin.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

The combination of encorafenib and binimetinib caused few skin issues.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Pulsed electric field treatment may help shrink untreated liver tumors.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

The new drug delivery system effectively targets lung cancer cells.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.